SmallCap Stocks @smallcapstockse

APHB: First Bacteriophage Candidate Enters the Clinic: By David Bautz, PhD NYSE:APHB On January 20, 2016, Ampl... bit.ly/1WvjHM5

CDTi starts shipments of DOC to Panasonic Ecology. The first step in the commercialization of the advanced mat... bit.ly/1WvjHLY

PBIO Boosts Balance Sheet by PIPE Financing: By Grant Zeng, CFA OTC:PBIO On Jan. 11, 2016, PBIO (OTC:PBIO) ann... bit.ly/1lw1VLb

1-13-16 SmallCapVoice Interview with Affinity Beverage Group Inc (SREH): Janon Costley, CEO of Village Tea Co... bit.ly/1V8yVFF

MBVX: Secures Funding to Conduct Two Phase 1 Clinical Trials with HuMab-5B1: By David Bautz, PhD OTC:MBVX On J... bit.ly/1V6oBOh

BMRA: Q2 Results, IBS Advisory Board Beefed Up Further: By Brian Marckx, CFA OBB:BMRA NYSE:VRX Q2 Results: Sof... bit.ly/1V6oBOe

RVX: Moving Along with Phase 3 BETonMACE; Re-iterating ‘Buy’ Rating & Increasing Price Target: By: Nisha Hiran... bit.ly/1V6oEtn

Newsletter, Current Positions, and Closed Positions Update - 1/18/16: RIGHT NOW! IN THE CURRENT NEWSLETTER! I... bit.ly/1SZyZsK

MTST: Q3 Results, Initial Launch Expected in 2016: By Brian Marckx, CFA OTC:MTST Q3 10-Q Filed: MetaStat (OTC:... bit.ly/1loC7ka

V.LMD: Misses Guidance But "Missed" Portion Pushed to Q1 2016: By Brian Marckx, CFA OTC:LEDIF TSX:LMD.V 2015 R... bit.ly/1SZyZsA

Midwest Energy Emissions (MEEC) – MATS Appears Intact with EPA’s Response: By Steven Ralston, CFA OTC:MEEC The... bit.ly/1RLlpKj

PRTX: Two Clinical Trials Underway for PRTX-100 in Immune Thrombocytopenia: By David Bautz, PhD OTC:PRTX Finan... bit.ly/1n2PmZA

1-11-16 SmallCapVoice Interview with Envoy Group Corp (ENVV): Bruce Leitch, COO for Envoy Group Corp (ENVV), c... bit.ly/1UNhQAF

Oramed Pharma (ORMP): Great Potential for its Unique Protein Oral Delivery (POD) Platform: By Grant Zeng, CFA ... bit.ly/1mUYUFX

VIVMF: Revenue Remains On A Tear, Up 28\% in Q4: By Brian Marckx, CFA OTC:VIVMF Q4 2015 Revenue Preannouncemen... bit.ly/1RpBx40

1-7-16 SmallCapVoice Interview with Auscrete Corp (ASCK): Auscrete CEO, John Sprovieri, called in to SmallCapV... bit.ly/1VP7mCe

ZMS.V: Revenue Remains Sluggish Despite Accelerating Order Flow: By Brian Marckx, CFA Financial ... bit.ly/1Zels5n

BOTA: Initiating Coverage on Biota Pharma: By Anita Dushyanth, PhD NASDAQ:BOTA BACKGROUNDViruses are known to ... bit.ly/1RiFbN6

SNGX has been busy in 2015 to advance its clinical programs.: By Grant Zeng, CFA OBB:SNGX Soligenix (OBB:SNGX)... bit.ly/1VFFAry

FNJN Raising Estimates: New Mystery License Agreement Signed in Q4 2015: By Lisa Thompson NASDAQ:FNJN With the... bit.ly/1kHBUrW